Építés alatt – nem éles oldal
Belépés
VisszavonvaFázis nélkül

Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Thoracic Aortic Aneurysms and Chronic Dissections

A legfontosabb adatok

Ki végzi
University Hospital, Toulouse
Hol
Franciaország2 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Visszavonva
Kezdés
2019. jan.
Befejezés
2026. febr.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Valiant Mona LSA Thoracic Stent Graft System
A regiszteradat frissítve
2020. augusztus 26.
Miért állt le
Production of the medical device was stopped

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 27 feltétel megnézéseKevesebb

Ki vehet részt

  • Subject is at least 18 years of age
  • Subject understands and has signed an Informed Consent
  • Subject must be considered a candidate for revascularization of the LSA
  • Subject must be able to tolerate a surgical revascularization of the LSA
  • Subject has a descending thoracic aneurysm (DTA) which will require coverage of the LSA
  • Subject has a healthy, non-diseased aortic proximal seal zone of at least 10 mm from the left carotid to the LSA and at least 5 mm landing zone distal to the LSA and proximal to the start of the aneurysm/ulcer/or the proximal entry tear for dissection
  • Subject has a non-diseased aortic diameter between 25 mm and 42 mm (fusiform/saccular aneurysms or penetrating ulcers) or 28 mm to 44 mm (chronic type B dissections),
  • Subject has a LSA with a diameter between 8 mm and 13 mm
  • Subject has sufficient landing zone within the LSA to accommodate the BSG without occlusion of any significant vessels
  • Subject has patent brachial arteries, iliac or femoral arteries (without circumferential calcifications and a diameter of ≥ 10mm), or can tolerate a conduit that will allow endovascular access to the aneurysmal site with the delivery system of the appropriate sized device chosen for treatment
  • Subject has a condition requiring prospective revascularization of the LSA

Ki nem vehet részt

  • Treatment with the Valiant Mona LSA Thoracic Stent Graft system would require intentional coverage of the left common carotid artery with the stent graft fabric
  • Subject has coronary artery disease with unstable angina and has not received treatment
  • Subject is currently participating in an investigational drug or device clinical trial that would interfere with the observations of this study
  • Subject has prohibitive calcification, occlusive disease, or tortuosity of intended fixation sites
  • Subject has a known allergy or intolerance to the device components
  • Subject has a connective tissue disease (e.g. Marfan's syndrome, medial degeneration)
  • Subject has active systemic infection and/or a mycotic aneurysm
  • Subject has a history of bleeding diathesis, coagulopathy, or refuses blood transfusion
  • Subject has a known hypersensitivity or contraindication to anticoagulants or contrast media, which is not amenable to pre-treatment
  • Subject is in acute renal failure or has renal insufficiency with a serum creatinine ≥ 2.0 mg/dL or is on dialysis
  • Subject has an aneurysmal, tortuous, or atherosclerotic LSA, conflicting the branch graft insertion
  • Subject has an aortic atheroma classified as grade IV or grade V
  • Subject has significant and/or circumferential aortic mural thrombus at either the proximal or distal attachment sites that would compromise fixation and seal of the device
  • Subject is a pregnant or breastfeeding female
  • Subject has other medical, social, or psychological problems that, in the opinion of the investigator, will interfere with treatment and follow-up procedures
  • Subject has a life expectancy of less than 1 year

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

To ensure adequate seal of currently available stent grafts, a proximal 20 mm of healthy aorta is recommended. Extending the proximal landing zone into the arch by intentional covering of the left subclavian artery (LSA) without revascularization expose to serious neurologic complications. Serious risks are also known to accompany subclavian revascularization. The Valiant Mona LSA Thoracic Stent Graft System (Medtronic,Santa Rosa, Calif) consists of a main stent graft and a branch stent graft designed to maintain LSA patency. The purpose of this study is to characterize the safety and effectiveness of this device for the treatment of Aneurysms and chronic Type B dissections of the arch.

A vizsgálat csoportja

  • Valiant Mona LSA Thoracic Stent Graft SystemA vizsgált kezelés

    The Valiant Mona LSA Thoracic Stent Graft System is administered.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2020. augusztus 26.